SCHEMBL8185149

SCHEMBL8185149

CCc1cc2c(NCCc3ccccc3)nc(-c3ccc(C(=O)O)cc3)nc2s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 3/20 0.55
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 1/20 0.50
PDE5A O76074 1/20 0.48
CSNK2A1 P68400 3/20 0.48
SLC6A3 Q01959 2/20 0.47
CSNK2A2 P19784 2/20 0.46
CSNK2B P67870 2/20 0.46
P2RY12 Q9H244 3/20 0.45
MAPK1 P28482 1/20 0.45
ICAM1 P05362 1/20 0.44
SELE P16581 1/20 0.44
VCAM1 P19320 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8179317 0.91 PRKCI (0.52) PRKCIKDM4EALDH1A1HSD17B10PDE5A
SCHEMBL8184738 0.90 ICAM1 (0.56) PRKCIKDM4EALDH1A1HSD17B10PDE5A
SCHEMBL8169995 0.88 PDE5A (0.50) PRKCIKDM4EALDH1A1HSD17B10PDE5A
SCHEMBL5120106 0.87 PRKCI (0.73) PRKCIKDM4EALDH1A1HSD17B10PDE5A
SCHEMBL8184884 0.86 PDE5A (0.50) PRKCIKDM4EPDE5ACSNK2A1SLC6A3
SCHEMBL8181651 0.85 PRKCI (0.48) PRKCIKDM4EALDH1A1HSD17B10PDE5A
SCHEMBL8185136 0.85 PRKCI (0.48) PRKCIKDM4EALDH1A1HSD17B10P2RY12
SCHEMBL8183227 0.85 PDE5A (0.47) PRKCIKDM4EALDH1A1PDE5ACSNK2A1
SCHEMBL8185712 0.82 PDE5A (0.47) KDM4EPDE5ACSNK2A1SLC6A3CSNK2A2
SCHEMBL5122806 0.82 GBA1 (0.64) PRKCIALDH1A1HSD17B10PDE5AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6130223-A Thienopyrimidine with phosphodiesterase V inhibiting effect MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-10-10 US disclosed
US-5948911-A Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 1999-09-07 US disclosed